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Abstract
Background—Assessment of fall risk in an individual with Parkinson disease (PD) is a critical 
yet often time consuming component of patient care. Recently a simple clinical prediction tool 
based only on fall history in the previous year, freezing of gait in the past month, and gait velocity 
<1.1 m/s was developed and accurately predicted future falls in a sample of individuals with PD.
METHODS—We sought to externally validate the utility of the tool by administering it to a 
different cohort of 171 individuals with PD. Falls were monitored prospectively for 6 months 
following predictor assessment.
RESULTS—The tool accurately discriminated future fallers from non-fallers (area under the 
curve [AUC] = 0.83; 95% CI 0.76 –0.89), comparable to the developmental study.
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CONCLUSION—The results validated the utility of the tool for allowing clinicians to quickly 
and accurately identify an individual’s risk of an impending fall.
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1. Introduction
Falls among individuals with Parkinson disease (PD) are prevalent, frequently recurrent, and 
disabling [1]. Fall incidence generally increases with disease progression, especially from 
early to middle stages. Commonly identified fall risk factors include a past history of falls, 
freezing of gait (FOG), impaired balance, and orthostatic hypotension [2]. Nonetheless there 
is a wide range of frequency of falling, and disease severity does not appear to be an 
accurate predictor of a future fall [2]. Thus, although much is known about falls and fall risk 
in PD, a clinician’s ability to accurately predict the absolute risk of an impending fall for an 
individual patient remains a significant challenge.
Currently a variety of standardized balance assessment tools like the Functional Gait 
Assessment [3] and Mini-Balance Evaluation Systems Test [4] are used to predict the risk of 
future falls in individuals with PD. While these measures have demonstrated relatively high 
accuracy for predicting falls (as measured by the area under the receiver operating 
characteristic curve (AUC) ≥0.80), they can be time-consuming and require specialized 
equipment. Recently, Paul and colleagues developed a simple clinical prediction tool based 
only on history of at least one fall in the past year, FOG in the past month, and gait speed 
<1.1 m/s [5]. The tool, which easily could be adopted in routine patient care, discriminated 
near term (i.e. 6 month) future fallers with high accuracy (AUC, 0.80; 95% CI 0.73–0.86).
Clinical prediction tools need to be externally validated to ensure their generalizability, 
accuracy, and clinical utility [6]. The clinical prediction tool [5] was internally validated 
using a sample of individuals with PD. The purpose of the present study was to externally 
validate the tool in a different cohort of persons with PD [7]. We hypothesized that the tool 
would demonstrate high accuracy in discriminating future fallers in the longitudinal study, 
comparable to that in the original developmental study [5].
2. Participants and methods
Participants selected for the external validation study were enrolled in a 2-year multicenter 
longitudinal cohort study designed to monitor the progression of disability and quality of life 
[7]. Institutional review board approval was obtained at each participating institution, and all 
participants provided written and informed consent. Community-dwelling individuals over 
age 40 were included if they had been diagnosed by a neurologist with idiopathic PD, 
determined to be between Hoehn & Yahr Stages I-IV (mild to moderatel disease severity), 
and scored ≥ 24 on the Mini-mental State Examination. Individuals were excluded if they 
had been diagnosed with atypical parkinsonism or had previous surgical intervention 
specifically for PD (e.g. deep brain stimulation). Assessments were conducted at 6-month 
intervals for a total of 24 months. All assessments were performed by a physical therapist at 
Duncan et al. Page 2
Parkinsonism Relat Disord. Author manuscript; available in PMC 2016 August 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
the University of Utah, Boston University, Washington University in St. Louis, or 
University of Alabama at Birmingham. Participants were assessed in the “on” state, defined 
as 1–2 to hours following anti-PD medication administration. Demographic information, PD 
profile and severity of motor signs were collected at baseline and quantified using the motor 
section of the Movement Disorders Society Unified Parkinson’s Disease Rating Scale 
(MDS-UPDRS-III).
To validate the results of the fall prediction tool in the original developmental sample [5], 
we used data collected at baseline, 6 months, and 12 months. For the first predictor variable, 
i.e. the occurrence of at least one fall during the previous year, we combined retrospective 6-
month fall history data from the baseline and 6-month assessments [6]. Fall history was 
determined using a forced-response paradigm, in which choices included none, once, 2–10 
times, weekly, or daily. Falls were defined as unintentionally coming to rest on the ground 
or other lower surface without being exposed to overwhelming external force or a major 
internal event. For the second and third predictor variables, we used FOG and gait speed 
data that were collected at the 6-month assessment only. FOG was defined as sudden and 
transient motor blocks when initiating or continuing walking [9]. In concert with Paul et al. 
[5], FOG was determined using the answer to Question 3 of the FOG Questionnaire (FOG-
Q) [8], which asks “Do you feel that your feet get glued to the floor while walking, making a 
turn, or when trying to initiate walking?” Participants reporting an answer greater than or 
equal to 1, which indicates experiencing freezing at least once monthly, were classified as 
having a positive FOG history. Self-selected gait speed <1.1 m/s was determined using the 
mean of two gait speed trials collected during a 10-m walk. The 10-m walk was conducted 
in a wide hallway and the time (seconds) to complete the walk was recorded using a 
stopwatch. Participants were allowed to use assistive devices if necessary. For the outcome 
variable, the occurrence of at least one fall during the 6-month period immediately following 
the assessment of predictor variables, we used 6-month fall history that had been collected at 
the 12-month assessment.
2.1. Data analysis
The external validation analysis included only those participants with complete fall history 
data. Among those participants, there were no missing FOG or gait speed data. The faller 
and non-faller groups were compared on demographic, PD profile, and physical 
performance measures using t-tests for independent samples (α = 0.05). A logistic 
regression model was used to evaluate how well the three predictor variables (i.e. at least 
one fall in the past year (yes/no)), freezing of gait within the past month (yes/no), and self-
selected gait speed <1.1 m/sec (yes/no) predicted the occurrence of at least one fall (yes/no) 
during the 6 months following predictor assessment. Model assumptions were examined 
without evidence of significant violations. Calibration, or distribution of predicted risk, was 
examined using the Hosmer–Lemeshow test (Table 2). A chi-square (χ2) contingency table 
and AUC were used to determine the discriminative ability of the clinical prediction tool and 
to calculate sensitivity and specificity. All analyses were performed with SPSS version 19 
(IBM Corporation, NY).
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3. Results
The external validation cohort included 171 participants with PD (Table 1). Sixty-six 
(38.6%) participants reported at least one fall during the 6 months following predictor 
assessment. Additional baseline variables stratified by fallers vs. non-fallers in the 6 months 
following predictor assessment are presented in Table 1.
Similar to the developmental sample [7], a test of predictor variables against a constant-only 
model distinguished 6-month future fallers from non-fallers with high accuracy (χ2 [3, n = 
171] = 64.34, p < 0.001; AUC = 0.83 [95% CI 0.76–0.89]), sensitivity = 90.9% (95% CI 
81.30–96.60), specificity 65.7% (95% CI 55.80–74.70). The result generated a positive 
likelihood ratio of 2.65 (95% CI 2.10–3.49) and a negative likelihood ratio of 0.14 (95% CI 
0.05–0.30). A comparison of predictor variable data from each study appears in Table 2.
Risk categories for the external validation sample were calculated based on the proposed 
scoring criteria from Paul et al. [5] (Table 2). The validation sample had a similar risk 
gradient as the development sample (Table 2 and Supplemental Digital Content) and 
calibration on average was correct. The Hosmer–Lemeshow test indicated no lack of fit 
between predicted and observed fallers (χ2 = 2.5 (df = 5, p = 0.77)). The largest discrepancy 
between the external validation sample and the developmental sample was noted in the 
relatively lower estimated probability of falling for the low risk category (n = 4).
4. Discussion
This study externally validated the accuracy of the fall prediction tool by meeting and 
exceeded the accuracy reported in the developmental study [5,6,9]. The results supported the 
assertion that the clinical prediction tool allows for accurate identification of individuals 
with PD who are at high risk of an impending fall. Such information should serve as a 
starting point for in-depth examination of additional risk factors (e.g. physiologic; cognitive) 
and may facilitate the rapid implementation of fall prevention strategies [2]. The simple tool 
takes less than five minutes to administer. Fall and FOG history can be gathered on patient 
intake forms prior to seeing the provider. Preferred gait speed can be easily collected by 
timing (in seconds) how long it takes a patient to walk a short distance (e.g., 10m) and 
reported (in m/s) similarly to other vital signs (e.g. heart rate, blood pressure). (See 
Supplemental Digital Content detailing the prediction tool).
Our findings confirmed that the occurrence of at least one fall in the past year is a strong 
predictor of future falls and emphasized the need for clinicians to screen for risk by asking 
all patients this simple question [10]. Our findings also highlighted the relevance of gait 
speed below 1.10 m/sec as a strong predictor of future falls. Our results, however, did not 
confirm the independent contribution of FOG to future falls. The latter finding may have 
been due to the different proportion of fallers in our sample compared to the development 
sample [5].
The largest discrepancy between our findings and those of the developmental study 
pertained to the relatively lower predictive accuracy of the tool for individuals with a low 
risk of an impending fall (Table 2). One reason for the discrepancy could have been related 
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to differences in sample characteristics. Our sample contained more individuals in earlier 
stages of the disease with lower disease severity. This difference warrants further 
investigation of the fall risk prediction tool in individuals identified at low fall risk for whom 
evolution to a higher fall risk category is uncertain.
The findings presented herein should be interpreted within the context of study limitations. 
First, our method of recording fall history had the potential to be less accurate than fall 
history collected using a diary. Although there are concerns of potential inaccuracy of 
relying on patient self-report of falls as opposed to a falls diary, patient recall is the current 
standard of care for gathering this data in clinical practice [11]. The necessity of this 
information is reflected in current position statements and guidelines for quality care in PD 
[10–12]. Future research should investigate the impact of the tool in clinical practice as well 
as examine the potential benefit of adding a history of recurrent falls to the accuracy of the 
fall prediction tool [9].
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Table 1
Baseline characteristics of fallers and non-fallers.
Variable Non-fallers (n = 105) Fallers (n = 66) p-value
Demographics and PD profile
Women, n (%) 44 (42) 30 (46) 0.38
Age, years 65.51 (9.13) 68.55(9.53) 0.04
Body mass index (kg/m2) 27.34 (5.70) 27.62 (7.88) 0.79
Physical activity scale for the elderly; Range 0–361 165.46 (88.18) 114.73 (81.36) 0.00
Any fall in previous 12 months, n (%) 36 (34) 60 (91) 0.00
Parkinson’s disease duration, years 4.75 (3.81) 6.56 (4.21) 0.00
MDS-Unified Parkinson’s disease rating: motor score; Range, 0–132 29.96 (10.79) 35.00 (15.36) 0.01
FOG in past month, n (%) 38 (36) 42 (64) 0.00
FOG severity; Range, 0–16* 2.01 (3.11) 4.56 (4.17) 0.00
Physical performance measures
Functional gait assessment (0–30) 22.59 (4.96) 17.62 (6.65) 0.00
Timed up and go (seconds) 9.83 (3.95) 13.30 (7.76) 0.00
10m walk: self selected speed (m/s) 1.26 (0.23) 1.10 (0.24) 0.07
10m walk <1.1 m/s 26 (25) 34 (52) 0.00
10m walk: max speed (m/s) 1.71 (0.37) 1.45 (0.35) 0.03
6min walk (meters) 494.75 (112.31) 392.74 (95.44) 0.00
Values are mean (SD) unless otherwise indicated.
Significant (p < 0.05) univariate comparisons in bold.
FOG in past month = yes/no based on question 3 of the FOGQ.
FOG severity was calculated as the sum of items 3–6 on the FOGQ.
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Table 2
Multivariate model coefficients and predicted probability of falling according to risk category for validation 
sample and development sample.
Predictor variable Validation sample Development sample
Regression coefficient OR (95% CI) Regression coefficient OR (95% CI)
Fell in previous 12 mo, 
yes/no
2.83 (1.84, 3.81) 16.90 (6.30, 45.00) 1.76 (1.10, 2.42) 5.80 (3.00, 11.22)
FOG in past mo, yes/no 0.05 (30.76, 0.88) 1.06 (0.47, 2.40) 0.87 (0.17, 1.60) 2.39 (1.19, 4.80)
Self-selected gait speed 
<1.1 m/s, yes/no
0.87 (0.07, 1.67) 2.38 (1.07, 5.31) 0.62 (30.04, 1.27) 1.86 (0.96, 3.58)
Risk categorya Number of participants 
who fell/total number of 
participants scoring in this 
category
Predicted (actual) 
probability of falling, 
%
Number of participants 
who fell/total number of 
participants scoring in this 
category
Predicted (actual) 
probability of 
falling, %
Low (0) 4/47 1 (9) 8/43 17 (19)
Med (>0 to <8) 15/53 30 (28) 36/73 51 (49)
High (>8) 47/71 66 (66) 76/89 85 (85)
aWeights are assigned to each of the three predictor variables based on the regression coefficients of the 3-predictor regression (ie, falling in past 
month = 6, freezing of gait in the past month = 3, gait speed <1.1 m per second = 2). The sum of the predictor weights give a maximum score of 11 
and a minimum score of 0. Probability of falling in the next 6 months is then classified (based on the sum of the predictor weights) as low (0), 
moderate (>0 to < 8) or high (≥8) [7].
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